{"pmid":32447298,"title":"Approaches to global stroke care during the COVID-19 pandemic.","text":["Approaches to global stroke care during the COVID-19 pandemic.","Stroke Vasc Neurol","Liu, Liping","Wang, David","Brainin, Michael","Elkind, Mitchell S V","Leira, Enrique","Wang, Yongjun","32447298"],"journal":"Stroke Vasc Neurol","authors":["Liu, Liping","Wang, David","Brainin, Michael","Elkind, Mitchell S V","Leira, Enrique","Wang, Yongjun"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447298","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/svn-2020-000429","keywords":["infection","stroke"],"topics":["Prevention"],"weight":1,"_version_":1667698385893720064,"score":9.490897,"similar":[{"pmid":32310017,"title":"COVID-19 and stroke-A global World Stroke Organization perspective.","text":["COVID-19 and stroke-A global World Stroke Organization perspective.","The COVID-19 pandemic affecting all parts of the world is having huge implications for stroke care. Not only do stroke patients appear to be more susceptible to severe infection, but the pandemic is having major implications on how we deliver stroke care, while ensuing safety of both our patients and health care professionals. COVID-19 infection itself has also been described as a risk factor for stroke. The World Stroke Organization has been monitoring the impact of the pandemic globally, and has identified an initial marked fall in stroke presentations as well as a widespread impact on stroke services. The pandemic is changing the way we deliver care, and has highlighted the enormous potential of telemedicine in stroke care.","Int J Stroke","Markus, Hugh S","Brainin, Michael","32310017"],"abstract":["The COVID-19 pandemic affecting all parts of the world is having huge implications for stroke care. Not only do stroke patients appear to be more susceptible to severe infection, but the pandemic is having major implications on how we deliver stroke care, while ensuing safety of both our patients and health care professionals. COVID-19 infection itself has also been described as a risk factor for stroke. The World Stroke Organization has been monitoring the impact of the pandemic globally, and has identified an initial marked fall in stroke presentations as well as a widespread impact on stroke services. The pandemic is changing the way we deliver care, and has highlighted the enormous potential of telemedicine in stroke care."],"journal":"Int J Stroke","authors":["Markus, Hugh S","Brainin, Michael"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310017","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1177/1747493020923472","keywords":["covid-19","intensive care unit","world stroke organization","healthcare systems","pandemic","stroke"],"topics":["Prevention"],"weight":1,"_version_":1666138491246870529,"score":70.40933},{"pmid":32464707,"title":"Macrothrombosis and stroke in patients with mild Covid-19 infection.","text":["Macrothrombosis and stroke in patients with mild Covid-19 infection.","Coronavirus disease 2019 (COVID-19) is a pandemic disease currently affecting millions of people worldwide. Its neurological implications are poorly understood, and further study is urgently required. A hypercoagulable state has been reported in patients with severe COVID-19, but nothing is known about coagulopathy in patients with milder disease. We describe cases of patients in New York City presenting with stroke secondary to large vessel thrombosis without occlusion, incidentally found to have COVID-19 with only mild respiratory symptoms. This is in contrast to the venous thrombosis and microangiopathy that has been reported in patients with severe COVID-19. Our cases suggest that even in the absence of severe disease, patients with COVID-19 may be at increased risk of thrombus formation leading to stroke, perhaps due to viral involvement of the endothelium. Further systematic study is needed, since this may have implications for primary and secondary stroke prevention in patients with COVID-19.","J Thromb Haemost","Fara, Michael G","Stein, Laura K","Skliut, Maryna","Morgello, Susan","Fifi, Johanna T","Dhamoon, Mandip S","32464707"],"abstract":["Coronavirus disease 2019 (COVID-19) is a pandemic disease currently affecting millions of people worldwide. Its neurological implications are poorly understood, and further study is urgently required. A hypercoagulable state has been reported in patients with severe COVID-19, but nothing is known about coagulopathy in patients with milder disease. We describe cases of patients in New York City presenting with stroke secondary to large vessel thrombosis without occlusion, incidentally found to have COVID-19 with only mild respiratory symptoms. This is in contrast to the venous thrombosis and microangiopathy that has been reported in patients with severe COVID-19. Our cases suggest that even in the absence of severe disease, patients with COVID-19 may be at increased risk of thrombus formation leading to stroke, perhaps due to viral involvement of the endothelium. Further systematic study is needed, since this may have implications for primary and secondary stroke prevention in patients with COVID-19."],"journal":"J Thromb Haemost","authors":["Fara, Michael G","Stein, Laura K","Skliut, Maryna","Morgello, Susan","Fifi, Johanna T","Dhamoon, Mandip S"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32464707","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jth.14938","keywords":["carotid artery thrombosis","coronavirus","infection","stroke","thrombosis"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1668079521324072960,"score":66.585495},{"pmid":32430481,"title":"Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic.","text":["Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic.","BACKGROUND: Authors have noticed an increase in lung apex abnormalities on CT angiography (CTA) of the head and neck performed for stroke workup during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVE: To evaluate the incidence of these CTA findings and their relation to COVID-19 infection. METHODS: In this retrospective multicenter institutional review board-approved study, assessment was made of CTA findings of code patients who had a stroke between March 16 and April 5, 2020 at six hospitals across New York City. Demographic data, comorbidities, COVID-19 status, and neurological findings were collected. Assessment of COVID-19 related lung findings on CTA was made blinded to COVID-19 status. Incidence rates of COVID-19 related apical findings were assessed in all code patients who had a stroke and in patients with a stroke confirmed by imaging. RESULTS: The cohort consisted of a total of 118 patients with mean+/-SD age of 64.9+/-15.7 years and 57.6% (68/118) were male. Among all code patients who had a stroke, 28% (33/118) had COVID-19 related lung findings. RT-PCR was positive for COVID-19 in 93.9% (31/33) of these patients with apical CTA findings.Among patients who had a stroke confirmed by imaging, 37.5% (18/48) had COVID-19 related apical findings. RT-PCR was positive for COVID-19 in all (18/18) of these patients with apical findings. CONCLUSION: The incidence of COVID-19 related lung findings in stroke CTA scans was 28% in all code patients who had a stroke and 37.5% in patients with a stroke confirmed by imaging. Stroke teams should closely assess the lung apices during this COVID-19 pandemic as CTA findings may be the first indicator of COVID-19 infection.","J Neurointerv Surg","Kihira, Shingo","Schefflein, Javin","Chung, Michael","Mahmoudi, Keon","Rigney, Brian","Delman, Bradley N","Mocco, J","Doshi, Amish","Belani, Puneet","32430481"],"abstract":["BACKGROUND: Authors have noticed an increase in lung apex abnormalities on CT angiography (CTA) of the head and neck performed for stroke workup during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVE: To evaluate the incidence of these CTA findings and their relation to COVID-19 infection. METHODS: In this retrospective multicenter institutional review board-approved study, assessment was made of CTA findings of code patients who had a stroke between March 16 and April 5, 2020 at six hospitals across New York City. Demographic data, comorbidities, COVID-19 status, and neurological findings were collected. Assessment of COVID-19 related lung findings on CTA was made blinded to COVID-19 status. Incidence rates of COVID-19 related apical findings were assessed in all code patients who had a stroke and in patients with a stroke confirmed by imaging. RESULTS: The cohort consisted of a total of 118 patients with mean+/-SD age of 64.9+/-15.7 years and 57.6% (68/118) were male. Among all code patients who had a stroke, 28% (33/118) had COVID-19 related lung findings. RT-PCR was positive for COVID-19 in 93.9% (31/33) of these patients with apical CTA findings.Among patients who had a stroke confirmed by imaging, 37.5% (18/48) had COVID-19 related apical findings. RT-PCR was positive for COVID-19 in all (18/18) of these patients with apical findings. CONCLUSION: The incidence of COVID-19 related lung findings in stroke CTA scans was 28% in all code patients who had a stroke and 37.5% in patients with a stroke confirmed by imaging. Stroke teams should closely assess the lung apices during this COVID-19 pandemic as CTA findings may be the first indicator of COVID-19 infection."],"journal":"J Neurointerv Surg","authors":["Kihira, Shingo","Schefflein, Javin","Chung, Michael","Mahmoudi, Keon","Rigney, Brian","Delman, Bradley N","Mocco, J","Doshi, Amish","Belani, Puneet"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430481","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/neurintsurg-2020-016188","keywords":["ct angiography","infection","stroke"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667342288255188993,"score":65.02138},{"pmid":32434728,"title":"A Stroke Care Model at an Academic, Comprehensive Stroke Center During the 2020 COVID-19 Pandemic.","text":["A Stroke Care Model at an Academic, Comprehensive Stroke Center During the 2020 COVID-19 Pandemic.","BACKGROUND AND PURPOSE: The COVID-19 pandemic has required the adaptation of hyperacute stroke care (including stroke code pathways) and hospital stroke management. There remains a need to provide rapid and comprehensive assessment to acute stroke patients while reducing the risk of COVID-19 exposure, protecting healthcare providers, and preserving personal protective equipment (PPE) supplies. While the COVID infection is typically not a primary cerebrovascular condition, the downstream effects of this pandemic force adjustments to stroke care pathways to maintain optimal stroke patient outcomes. METHODS: The University of California San Diego (UCSD) Health System encompasses two academic, Comprehensive Stroke Centers (CSCs). The UCSD Stroke Center reviewed the national COVID-19 crisis and implications on stroke care. All current resources for stroke care were identified and adapted to include COVID-19 screening. The adjusted model focused on comprehensive and rapid acute stroke treatment, reduction of exposure to the healthcare team, and preservation of PPE. AIMS: The adjusted pathways implement telestroke assessments as a specific option for all inpatient and outpatient encounters and accounts for when telemedicine systems are not available or functional. COVID screening is done on all stroke patients. We outline a model of hyperacute stroke evaluation in an adapted stroke code protocol and novel methods of stroke patient management. CONCLUSIONS: The overall goal of the model is to preserve patient access and outcomes while decreasing potential COVID-19 exposure to patients and healthcare providers. This model also serves to reduce the use of vital PPE. It is critical that stroke providers share best practices via academic and vetted social media platforms for rapid dissemination of tools and care models during the COVID-19 crisis.","J Stroke Cerebrovasc Dis","Meyer, Dawn","Meyer, Brett C","Rapp, Karen S","Modir, Royya","Agrawal, Kunal","Hailey, Lovella","Mortin, Melissa","Lane, Richard","Ranasinghe, Tamra","Sorace, Brian","von Kleist, Tara D","Perrinez, Emily","Nabulsi, Mohammed","Hemmen, Thomas","32434728"],"abstract":["BACKGROUND AND PURPOSE: The COVID-19 pandemic has required the adaptation of hyperacute stroke care (including stroke code pathways) and hospital stroke management. There remains a need to provide rapid and comprehensive assessment to acute stroke patients while reducing the risk of COVID-19 exposure, protecting healthcare providers, and preserving personal protective equipment (PPE) supplies. While the COVID infection is typically not a primary cerebrovascular condition, the downstream effects of this pandemic force adjustments to stroke care pathways to maintain optimal stroke patient outcomes. METHODS: The University of California San Diego (UCSD) Health System encompasses two academic, Comprehensive Stroke Centers (CSCs). The UCSD Stroke Center reviewed the national COVID-19 crisis and implications on stroke care. All current resources for stroke care were identified and adapted to include COVID-19 screening. The adjusted model focused on comprehensive and rapid acute stroke treatment, reduction of exposure to the healthcare team, and preservation of PPE. AIMS: The adjusted pathways implement telestroke assessments as a specific option for all inpatient and outpatient encounters and accounts for when telemedicine systems are not available or functional. COVID screening is done on all stroke patients. We outline a model of hyperacute stroke evaluation in an adapted stroke code protocol and novel methods of stroke patient management. CONCLUSIONS: The overall goal of the model is to preserve patient access and outcomes while decreasing potential COVID-19 exposure to patients and healthcare providers. This model also serves to reduce the use of vital PPE. It is critical that stroke providers share best practices via academic and vetted social media platforms for rapid dissemination of tools and care models during the COVID-19 crisis."],"journal":"J Stroke Cerebrovasc Dis","authors":["Meyer, Dawn","Meyer, Brett C","Rapp, Karen S","Modir, Royya","Agrawal, Kunal","Hailey, Lovella","Mortin, Melissa","Lane, Richard","Ranasinghe, Tamra","Sorace, Brian","von Kleist, Tara D","Perrinez, Emily","Nabulsi, Mohammed","Hemmen, Thomas"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434728","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jstrokecerebrovasdis.2020.104927","keywords":["covid-19","stroke","stroke code","systems of care"],"topics":["Prevention"],"weight":1,"_version_":1667521393667866625,"score":64.061295},{"pmid":32451359,"title":"Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.","text":["Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.","BACKGROUND: COVID-19 infections have been shown to be associated with a range of thromboembolic disease. OBJECTIVE: To describe our endovascular experience in a consecutive series of patients with COVID-19 who presented with large vessel occlusions, and to describe unique findings in this population. METHODS: Mechanical thrombectomy was performed on five consecutive patients with COVID-19 with large vessel occlusions. A retrospective study of these patients was performed. Patient demographics, laboratory values, mechanical thrombectomy technique, and clinical and angiographic outcomes were reviewed. RESULTS: Four patients with COVID-19 presented with anterior circulation occlusions and one patient with COVID-19 presented with both anterior and posterior circulation occlusions. All patients had coagulation abnormalities. Mean patient age was 52.8 years. Three patients presented with an intracranial internal carotid artery occlusion. Two patients presented with an intracranial occlusion and a tandem thrombus in the carotid bulb. One patient presented with an occlusion in both the internal carotid and basilar arteries. Clot fragmentation and distal emboli to a new vascular territory were seen in two of five (40%) patients, and downstream emboli were seen in all five (100%) patients. Patient clinical outcome was generally poor in this series of patients with COVID-19 large vessel occlusion. CONCLUSION: Our series of patients with COVID-19 demonstrated coagulation abnormalities, and compared with our previous experience with mechanical thrombectomy in large vessel occlusion, this group of patients were younger, had tandem or multiple territory occlusions, a large clot burden, and a propensity for clot fragmentation. These patients present unique challenges that make successful revascularization difficult.","J Neurointerv Surg","Wang, Arthur","Mandigo, Grace K","Yim, Peter D","Meyers, Philip M","Lavine, Sean D","32451359"],"abstract":["BACKGROUND: COVID-19 infections have been shown to be associated with a range of thromboembolic disease. OBJECTIVE: To describe our endovascular experience in a consecutive series of patients with COVID-19 who presented with large vessel occlusions, and to describe unique findings in this population. METHODS: Mechanical thrombectomy was performed on five consecutive patients with COVID-19 with large vessel occlusions. A retrospective study of these patients was performed. Patient demographics, laboratory values, mechanical thrombectomy technique, and clinical and angiographic outcomes were reviewed. RESULTS: Four patients with COVID-19 presented with anterior circulation occlusions and one patient with COVID-19 presented with both anterior and posterior circulation occlusions. All patients had coagulation abnormalities. Mean patient age was 52.8 years. Three patients presented with an intracranial internal carotid artery occlusion. Two patients presented with an intracranial occlusion and a tandem thrombus in the carotid bulb. One patient presented with an occlusion in both the internal carotid and basilar arteries. Clot fragmentation and distal emboli to a new vascular territory were seen in two of five (40%) patients, and downstream emboli were seen in all five (100%) patients. Patient clinical outcome was generally poor in this series of patients with COVID-19 large vessel occlusion. CONCLUSION: Our series of patients with COVID-19 demonstrated coagulation abnormalities, and compared with our previous experience with mechanical thrombectomy in large vessel occlusion, this group of patients were younger, had tandem or multiple territory occlusions, a large clot burden, and a propensity for clot fragmentation. These patients present unique challenges that make successful revascularization difficult."],"journal":"J Neurointerv Surg","authors":["Wang, Arthur","Mandigo, Grace K","Yim, Peter D","Meyers, Philip M","Lavine, Sean D"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451359","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/neurintsurg-2020-016220","keywords":["embolic","infection","stroke"],"topics":["Diagnosis"],"weight":1,"_version_":1667881798571393024,"score":63.612816}]}